Also trades as: 0RC7.L (LSE) · $vol 0M
HNSA.ST STO
Hansa Biopharma AB (publ)
1W: +2.5%
1M: -25.4%
3M: -4.0%
YTD: -10.3%
1Y: +5.9%
3Y: -26.6%
5Y: -73.0%
kr 33.18 ($3.29)
-0.94 (-2.75%)
Weekly Expected Move ±6.2%
kr 29
kr 31
kr 33
kr 35
kr 37
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTMkr 189M
Revenue
-3.6% YoY
kr -770M
Net Income
-29.2% YoY
kr -546M
Free Cash Flow
+11.9% YoY
53.6%
Gross Margin
-361.9%
Op. Margin
-541.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE160.2%
ROA-80.7%
ROIC1185.5%
Valuation
P/E-4.2
P/B-6.5
EV/EBITDA-7.2
Leverage
Debt/Equity-1.99
Current Ratio1.25
Interest Cov.-3.1x
Quality Scores
Piotroski F2/9
Altman Z-0.10
Beneish M-3.75